Axe

Description

AXE Acne Control Body, Hand and Face Bar is formulated with Salicylic Acid, a well-known active ingredient for acne treatment. This product is designed to provide antibacterial properties, as indicated by its formulation as a Dove Care & Protect Antibacterial Beauty Bar. The combination of these components aims to effectively cleanse and treat acne-prone skin on various body parts, including the hands and face.

Uses and Indications

This drug is indicated for the treatment of acne. It is intended for use in patients diagnosed with this condition to help manage and reduce the severity of acne symptoms.

Dosage and Administration

The product should be applied to the body and face by lathering thoroughly. Following application, it is essential to rinse the area completely to ensure the removal of the product.

Contraindications

Use is contraindicated in children unless under adult supervision. In the event of accidental ingestion, immediate medical assistance or contact with a poison control center is required.

Warnings and Precautions

For external use only. The application of this product may lead to increased skin irritation and dryness, particularly if used concurrently with other topical acne medications. In the event of irritation, it is advised to limit the use to one topical acne medication at a time to mitigate adverse effects.

General precautions should be observed, including keeping the product out of reach of children, except when under adult supervision to prevent accidental ingestion or misuse.

In cases of accidental ingestion, immediate medical assistance should be sought, or a poison control center should be contacted without delay to ensure appropriate management.

Healthcare professionals are encouraged to monitor patients for signs of irritation and to provide guidance on the safe use of topical acne treatments to optimize therapeutic outcomes while minimizing risks.

Side Effects

Patients should be aware that this product is for external use only. The use of this product in conjunction with other topical acne medications may increase the likelihood of skin irritation and dryness. In the event that irritation occurs, it is recommended that patients limit their use to one topical acne medication at a time to minimize adverse reactions.

Drug Interactions

Concurrent use of this product with other topical acne medications may increase the risk of skin irritation and dryness. It is advisable to limit the use of topical acne treatments to one at a time to minimize the potential for adverse effects. If skin irritation occurs, the use of additional topical acne medications should be discontinued until the irritation resolves.

Packaging & NDC

Below are the non-prescription pack sizes of Axe (acne control body hand and face bar). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be kept out of reach of children except under adult supervision. In the event of accidental ingestion, immediate medical assistance should be sought, or a poison control center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population, given the lack of targeted data.

Pregnancy

There is no specific information regarding the use of AXE Acne Control Body, Hand and Face Bar Soap during pregnancy. The drug insert does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when recommending this product to women of childbearing potential and consider the lack of data on potential fetal impacts. It is advisable to weigh the benefits against any unknown risks when discussing the use of this product in pregnant patients.

Lactation

No specific information regarding nursing mothers or lactation is provided in the drug insert for AXE Acne Control Body, Hand and Face Bar. Therefore, the effects on breastfed infants and the excretion of the product in breast milk are not known. Healthcare professionals should exercise caution when recommending this product to lactating mothers.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the lack of detailed guidance necessitates careful clinical judgment and individualized patient assessment. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the overall clinical context when prescribing this medication to patients with liver problems, as the absence of specific guidance necessitates careful evaluation of potential risks and benefits.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and ensuring adequate circulation. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on clinical judgment.

Additionally, specific antidotes or treatments may be indicated depending on the substance involved in the overdose. Consultation with a poison control center or a medical toxicologist is recommended to guide management and ensure optimal patient outcomes.

Overall, vigilance and prompt intervention are critical in managing cases of suspected overdose, even in the absence of detailed information regarding specific overdosage effects.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children, ensuring that it is only accessible under adult supervision. It is important to emphasize the potential risks associated with accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help or contact a poison control center immediately. This guidance is crucial for ensuring the safety and well-being of both patients and their families.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers. It should be stored at room temperature, ideally in a cool, dry place. Care must be taken to protect the product from excessive heat and moisture. Freezing is not permitted, as it may compromise the integrity of the product. Once opened, any unused portion should be discarded to ensure safety and efficacy.

Additional Clinical Information

The route of administration for the medication is topical. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Axe, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)